ArticleJournal of molecular medicine (Berlin, Germany)2012

Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.

Ling-Jun Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.